Antibacterial agents in pediatrics
Susana Chavez-Bueno1, Terrence L Stull
1Department of Pediatrics, Section of Pediatric Infectious Diseases, University of Oklahoma Health Sciences Center, 940 NE 13th Street, Room 2B 2311, Oklahoma City, OK 73104, USA.
Infectious Disease Clinics of North America
|November 14, 2009
Summary
Pediatric antibiotics require more safety and efficacy studies. This review covers common antibacterial drugs for children and emerging treatments.
Area of Science:
- Pediatric Pharmacology
- Infectious Diseases
- Drug Safety
Background:
- Antibiotics are essential for treating pediatric infections.
- Many widely used antibiotics lack comprehensive pediatric safety and efficacy data.
- Pediatric antimicrobial use necessitates careful consideration of age-specific pharmacokinetics and pharmacodynamics.
Purpose of the Study:
- To review the pharmacologic properties of commonly prescribed pediatric antibacterials.
- To discuss the therapeutic applications of these agents in children.
- To highlight newer antibacterial agents under investigation for pediatric use.
Main Methods:
- Literature review of existing studies on pediatric antibiotic use.
- Analysis of pharmacologic data for commonly prescribed antibacterial drugs.
- Inclusion of information on emerging antibacterial agents in clinical trials.
Main Results:
- Detailed descriptions of the characteristics and uses of established pediatric antibiotics.
- Identification of knowledge gaps in pediatric antibiotic safety and efficacy.
- Overview of novel antibacterial agents with potential pediatric applications.
Conclusions:
- There is a critical need for further research into the safety and efficacy of antibiotics in children.
- Optimizing pediatric antibacterial therapy requires understanding drug-specific properties and patient factors.
- Ongoing clinical investigations offer promise for expanded pediatric antimicrobial options.
More Related Videos
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:27Chemical Agents for Microbial Control
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...